Cargando…
Effect of clinical levels of misonidazole on the response of tumour and normal tissues in the mouse to alkylating agents.
Experiments were carried out to determine whether the enhancement of alkylating-agent cytotoxicity seen after large single doses of misonidazole (MISO) in mouse tumours can also be achieved by prolonged exposure to low MISO levels similar to those which can be tolerated clinically. The level in mous...
Autores principales: | Brown, J. M., Hirst, D. G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1982
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011020/ https://www.ncbi.nlm.nih.gov/pubmed/7082556 |
Ejemplares similares
-
Enhancing effect of misonidazole on the response of the RIF-1 tumour to cyclophosphamide.
por: Law, M. P., et al.
Publicado: (1981) -
Distribution of misonidazole in human tumours and normal tissues.
por: Ash, D. V., et al.
Publicado: (1979) -
Misonidazole protects mouse tumour and normal tissues from the toxicity of oral CCNU.
por: Lee, F. Y., et al.
Publicado: (1985) -
Is tumour radiosensitization by misonidazole a general phenomenon?
por: Denekamp, J., et al.
Publicado: (1980) -
Enhancement of the action of alkylating agents by single high, or chronic low doses of misonidazole.
por: McNally, N. J., et al.
Publicado: (1983)